Comparison of Aminolevulinic Acid and Hexylester Aminolevulinate Induced Protoporphyrin IX Distribution in Human Bladder Cancer
Abstract
Purpose:
Successful photodynamic therapy of epithelial cancer requires a specific photosensitization of malignant tissue. We evaluate the intensity and localization of protoporphyrin IX (PpIX) in superficial transitional cell carcinoma and nonmalignant cells of the human bladder following topical administration of its precursor, either aminolevulinic acid (ALA) or hexylester aminolevulinate (HAL).
Materials and Methods:
Solutions of ALA or HAL were instilled into the bladder of 18 patients presenting with recurrent transitional cell carcinoma. The distribution of PpIX through the bladder wall was studied on frozen biopsies using fluorescence microscopy and correlated with pathological findings.
Results:
Topical bladder instillation with 180 mmol (3%) ALA administered for 6 hours or 8 mmol (0.2%) HAL administered for 4 hours gave similar results regarding intensity and tissue distribution of PpIX fluorescence, whereas 8 mmol HAL administered for 2 hours followed by 2 hours of resting time (2+2 hours concept) induced a PpIX fluorescence twice as high. The fluorescence remained limited to cancer cells. Only a trace of PpIX fluorescence was observed in suburothelial connective tissue, that is chorion, but none in the bladder smooth muscle regardless of experiment conditions.
Conclusions:
HAL is an excellent precursor for PpIX synthesis in bladder cancer. With the 2+2 hour topical administration condition it yielded the highest PpIX fluorescence intensity and fluorescence contrast between normal and malignant urothelial cells. This approach allows us to optimize PpIX tissue distribution for photodynamic therapy in superficial bladder cancer.
References
- 1 : Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B1992; 14: 275. Google Scholar
- 2 : Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res1997; 57: 1481. Google Scholar
- 3 : Optimisation of the formation and distribution of protoporphyrin IX in the urothelium: an in vitro approach. J Urol1999; 162: 546. Link, Google Scholar
- 4 : Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol1996; 155: 105. Link, Google Scholar
- 5 : Photodetection of early human bladder cancer based on the fluorescence of 5-aminolevulinic acid hexylester-induced protoporphyrin IX: a pilot study. Br J Cancer1999; 80: 185. Google Scholar
- 6 : Histological typing of urinary bladder tumors.. International Histological Classification of Tumors. Geneva: World Health Organization1973. Google Scholar
- 7 : UICC TNM Classification of Malignant Tumors. Berlin: Springer Verlag1992. Google Scholar
- 8 : Long-term results of whole bladder wall photodynamic therapy for carcinoma in situ of the bladder. Urology1995; 45: 763. Google Scholar
- 9 : Complications of whole bladder dihematoporphyrin ether photodynamic therapy. J Urol1989; 141: 1341. Link, Google Scholar
- 10 : Photodynamic therapy in superficial bladder cancer: past, present and future. Urol Res2001; 29: 396. Google Scholar
- 11 : Biodistribution of Photofrin II and 5-aminolevulinic acid-induced protoporphyrin IX in normal rat bladder and bladder tumor models: implications for photodynamic therapy. Photochem Photobiol1998; 67: 573. Google Scholar
- 12 : The fluorescence biodistribution and kinetics of aminolevulinic acid induced protoporphyrin IX in the bladder of a rat model with orthotopic urothelial carcinoma. J Urol2002; 167: 1848. Abstract, Google Scholar
- 13 : Biodistribution of protoporphyrin IX in rat urinary bladder after intravesical instillation of 5-aminolevulinic acid. J Urol1996; 155: 1744. Link, Google Scholar
- 14 : Photodynamic therapy on rat urinary bladder with intravesical instillation of 5-aminolevulinic acid: light diffusion and histological changes. J Urol1996; 155: 1749. Link, Google Scholar
- 15 : Quantitative studies of the kinetics of 5-aminolaevulinic acid-induced fluorescence in bladder transitional cell carcinoma. Br J Cancer1998; 78: 1113. Google Scholar
- 16 : Intravesical instillation of 5-aminolevulinic acid: the fluorescent metabolite is limited to urothelial cells. Urology1994; 44: 676. Google Scholar
- 17 : Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer. Br J Urol1996; 77: 667. Google Scholar
- 18 : Comparison of normal piglet bladder damage after PDT with oral or intravesical administration of ALA. Lasers Med Sci2002; 17: 238. Google Scholar
- 19 : First experience of hexyl-ester aminolevulinic acid induced fluorescence cystoscopy in patients with superficial bladder cancer. J Urol2002; 167: 160. abstract 644. Google Scholar
- 20 : Pharmacokinetics of 5-aminolevulinic acid-induced protoporphyrin IX in skin and blood. J Photochem Photobiol B1997; 40: 313. Google Scholar
From the Department of Urology (AM, PJ, HJL) and Institute of Pathology (LG), University Hospital, The Federal Institute of Technology (NL, J-PB) and the Institute of Physiology, Faculty of Medicine, University of Lausanne, Lausanne, Switzerland (PK)
